drugset / Trial / NCT01558947

Peri-operative Chemotherapy With ECX or XP in the Treatment of Advanced Gastric Cancer

NCT01558947 ↗

Phase 2 Unknown 2 enrolled Zhejiang Cancer Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to evaluate the safety and the effect of perioperative chemotherapy in the treatment of advanced gastric cancer.

Timeline

Start
2011-01
Primary completion
2012-12
Completion
2013-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Epirubicin Small molecule 50 mg/m2 —
Background Capecitabine Small molecule 1000 mg/m2 —
Background Cisplatin Other / unclassified 60 mg/m2 —

Indications